Live Breaking News & Updates on Thiel Marks Palantir|Page 1

Stay updated with breaking news from Thiel marks palantir. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Lithium Miner's German Smelter Plan Draws Billionaires


Lithium Miner’s German Smelter Plan Draws Billionaires
Bloomberg
1/12/2021
Eyk Henning and Christoph Rauwald
(Bloomberg) Rock Tech Lithium Inc. plans to raise $400 million to build a lithium refinery in Germany and has attracted support from billionaires including Peter Thiel investing in Europe’s push to create a local electric-vehicle battery industry.
The Canadian miner is in advanced talks with investors and sees the Brandenburg and Saxony-Anhalt regions as possible locations for the smelter, Chairman Dirk Harbecke said by phone.
Europe is expected to overtake China as the top EV market this year, spawning investment into the necessary infrastructure and local supply chains to reduce a dependence on Asian battery makers. ....

United States , United Kingdom , British Columbia , Alan Howard , Palantir Asia , Christian Angermayer , Peter Thiel , Kiyoshi Ota Bloomberg , Dirk Harbecke , Facebook Inc , Bloomberg Rock Tech Lithium Inc , Tesla Inc , Tech Lithium , Chairman Dirk Harbecke , Thiel Marks Palantir , Asia Push , Bloomberg Thiel Marks Palantir , Japan Venture , Rock Tech , Georgia Lake , North America , Corrects Thiel , ஒன்றுபட்டது மாநிலங்களில் , ஒன்றுபட்டது கிஂக்டம் , பிரிட்டிஷ் கொலம்பியா , ஆலன் ஹோவர்ட் ,

Thiel-Backed Developer of Covid-19 Therapy Surges in Debut


Thiel-Backed Developer of Covid-19 Therapy Surges in Debut
Bloomberg
12/11/2020
Kevin Orland
(Bloomberg) AbCellera Biologics Inc., which is developing an antibody treatment for Covid-19 with Eli Lilly & Co., nearly tripled in the first day of trading after its initial public offering.
Shares of the Vancouver-based company surged to $58.90 after being priced at $20 in the offering. The offering raised $483 million before commissions and expenses, making it the biggest Canadian pharmaceuticals IPO on record and the second-largest Canadian initial offering announced this year, according to data compiled by Bloomberg.
AbCellera is riding a wave of interest in companies whose products may be used to combat the pandemic. The firm is co-developing a monoclonal antibody treatment that U.S. regulators authorized last month as a therapy for people with mild-to-moderate Covid-19 symptoms. ....

Palantir Asia , Peter Thiel , Kiyoshi Ota Bloomberg , Facebook Inc , Paypal Holdings Inc , Credit Suisse Group , Palantir Technologies Inc , Bloomberg Abcellera Biologics Inc , Eli Lilly Co , Cellera Biologics Inc , Eli Lilly , Thiel Marks Palantir , Asia Push , Bloomberg Thiel Marks Palantir , Japan Venture , Paypal Holdings , Palantir Technologies , Suisse Group , பீட்டர் திீஏல் , முகநூல் இன்க் , பேபால் ஹோல்டிங்ஸ் இன்க் , கடன் ஸ்யூயி குழு , எலி லில்லி இணை , எலி லில்லி , ஆசியா மிகுதி , ஜப்பான் துணிகர ,